JOHNSON AND JOHNSON IN AVOID LIST....Stock already in daily time frame which already extended and may be entering in weekly timeframe Correction....SO may be Stock Expected to Trade in Range for next one year
This magical strategy works like a clock on almost any charts
Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading.
It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave.
The best timeframe for this strategy is Daily, Weekly and Monthly...
The share price of Johnson and Johnson looks ready to rebound from the major resistance-turned-support area, underpinned by the 23.6 per cent Fibonacci retracement level at 175.61, and resume climbing.
The underlying uptrend appears to be taking the form of a 1-5 impulse wave pattern, as postulated by the Elliott Wave Theory. Thus, the recent correction can be...
Hello everyone, as we all know the market action discounts everything :)
_________________________________Make sure to Like and Follow if you like the idea_________________________________
The Johnson & Johnson stock is having a great Bullish movement right now, In the last week, the stock price has risen from 173.05 and reached 179.47 today. That's more than...
Always DYOR and understand the dynamics of these OTC stocks (known for pump & dump) but the fundamentals here are what will ultimately drive Sunshine Biopharma to return to it's formerly glorious highs but for now, it's relegated to the fractional levels that we see. On it's face, it looks like a no-brainer . . company shedding debt, increasing earnings (still no...
Johnson & Johnson has been a profitable business to invest in for years. But its legal problems have grown steadily--the company has faced tens of thousands of lawsuits over talc alone.
And while so far the health care giant has managed to cope with its legal costs and remain profitable, that may not be the case in the future.
In addition, all these negative...
If there is any hope for the S&P right now it may very well come from the healthcare sector with mega blue chip Johnson & Johnson.
JNJ has managed to put in consecutive higher highs and higher lows on the weekly, and now also is confirming support on the .618 fibonacci level at $165.40.
However, there appears to still be much selling pressure at just above $168,...
Johnson & Johnson is a major manufacturer of cosmetic and sanitary products, as well as medical equipment and medicines. The company was founded in 1886.
In general, the history of the company is mega-successful. The corporation expanded through the purchases of competitors and gained more and more market share in its areas.
The company's progress is confirmed...
Welcome to this analysis about the stock JOHNSON&JOHNSON, looking at the 4-hour timeframe perspectives. In my analysis recently I detected an interesting formational structure with J&J which has the ability to show up a determined breakout. As the corona pandemic moved on there emerged several pharmacy companies wanted to invent the covid-19 vaccines,...
The share price appears unable to break out above the historic resistance level at 170.00, which represents a very strong bearish signal.
Moreover, the price action has recently established a broad 1-5 impulse wave pattern, as postulated by the Elliott Wave Theory, as well as having developed an Ascending Wedge. Both of these developments confirm the bearish...
Johnson & Johnson just posted better-than-expected EPS data for Q1. Meanwhile, the company's shares continue to strengthen above the 50-day MA (in green).
A potential breakout above the clearly visible Bullish Pennant would signify mounting bullish momentum, which can be taken advantage of. Bulls can catch a potential upswing towards the major resistance level...
With the news that the CDC is pausing J&J vaccine distribution due to blood clot issues.
I'm assuming we should see it tank at the open? You're guess is as good as mine.
In my opinion if we see price drop it should be a good time to buy, because everyone else is selling.
The level I'm interested in is $147-$150.
It is an untested point of control where...
In my work, I always try to combine fundamental analysis and technical analysis.
They are both important, especially on a topic as important as the covid vaccine.
Johnson & Johnson is about to be marketed, after the approval of the EMA on 11 March.
Exactly after the announcement, I bought the stock.
The JnJ vaccine has a much lower distribution cost than Pfizer...
With good news out regarding the one-shot vaccine and multiple bullish signals this could be a great play.
Descending wedge and potential inverse head and shoulders could see price rise to £170 and beyond.
Beware of some resistance around £165.